GR3029322T3 - Improvements relating to the detection of viruses - Google Patents

Improvements relating to the detection of viruses

Info

Publication number
GR3029322T3
GR3029322T3 GR990400408T GR990400408T GR3029322T3 GR 3029322 T3 GR3029322 T3 GR 3029322T3 GR 990400408 T GR990400408 T GR 990400408T GR 990400408 T GR990400408 T GR 990400408T GR 3029322 T3 GR3029322 T3 GR 3029322T3
Authority
GR
Greece
Prior art keywords
cmv
viruses
detection
improvements relating
variation
Prior art date
Application number
GR990400408T
Other languages
English (en)
Inventor
Jane Grundy
Vincent Emery
Paul Griffiths
Original Assignee
Royal Free Hosp School Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Free Hosp School Med filed Critical Royal Free Hosp School Med
Publication of GR3029322T3 publication Critical patent/GR3029322T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR990400408T 1990-04-11 1999-02-10 Improvements relating to the detection of viruses GR3029322T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909008223A GB9008223D0 (en) 1990-04-11 1990-04-11 Improvements relating to the detection of viruses
PCT/GB1991/000574 WO1991015586A1 (en) 1990-04-11 1991-04-11 Improvements relating to the detection of viruses

Publications (1)

Publication Number Publication Date
GR3029322T3 true GR3029322T3 (en) 1999-05-28

Family

ID=10674284

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400408T GR3029322T3 (en) 1990-04-11 1999-02-10 Improvements relating to the detection of viruses

Country Status (10)

Country Link
US (2) US5567582A (el)
EP (1) EP0527785B1 (el)
JP (2) JP3140773B2 (el)
AT (1) ATE174056T1 (el)
DE (1) DE69130562T2 (el)
DK (1) DK0527785T3 (el)
ES (1) ES2125236T3 (el)
GB (1) GB9008223D0 (el)
GR (1) GR3029322T3 (el)
WO (1) WO1991015586A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427469B2 (en) * 2002-11-05 2008-09-23 Institut Pasteur Method of treating cytomegalovirus with DC-SIGN blockers
EP1562628B1 (en) * 2002-11-05 2009-04-15 Institut Pasteur Dc-sign blockers and their use for preventing or treating viral infections.
US7272333B2 (en) * 2005-06-30 2007-09-18 Xerox Corporation Image quality measurements using linear array in specular mode
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
ES2682596T3 (es) 2008-07-16 2018-09-21 Institute For Research In Biomedicine Anticuerpos neutralizantes del citomegalovirus humano y uso de los mismos
MX2012007489A (es) 2009-12-23 2012-11-29 4Antibody Ag Miembros enlazadores para citomegalovirus.
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TW202413391A (zh) 2020-06-21 2024-04-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
US5124440A (en) * 1986-11-24 1992-06-23 The Childrens Hospital, Inc. Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
US5547834A (en) * 1988-01-29 1996-08-20 Chiron Corporation Recombinant CMV neutralizing proteins
WO1989007143A1 (en) * 1988-01-29 1989-08-10 Chiron Corporation Recombinant cmv neutralizing proteins

Also Published As

Publication number Publication date
JP3140773B2 (ja) 2001-03-05
WO1991015586A1 (en) 1991-10-17
JP2000333685A (ja) 2000-12-05
JP3141024B2 (ja) 2001-03-05
US5883225A (en) 1999-03-16
DE69130562T2 (de) 1999-04-29
ES2125236T3 (es) 1999-03-01
GB9008223D0 (en) 1990-06-13
ATE174056T1 (de) 1998-12-15
US5567582A (en) 1996-10-22
JPH05506985A (ja) 1993-10-14
DE69130562D1 (de) 1999-01-14
EP0527785A1 (en) 1993-02-24
EP0527785B1 (en) 1998-12-02
DK0527785T3 (da) 1999-08-16

Similar Documents

Publication Publication Date Title
Lurain et al. Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
AU6769590A (en) Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav)
AU654111B2 (en) Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
AU665952B2 (en) Methods and reagents for hepatitis C detection
GB9008223D0 (en) Improvements relating to the detection of viruses
CA2084339A1 (en) Method of sexing bovine embryos
Frenkel et al. Herpes simplex virus: genome size and redundancy studied by renaturation kinetics
Deback et al. Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains
Davis et al. Numerous length polymorphisms at short tandem repeats in human cytomegalovirus
Stow Mutagenesis of a herpes simplex virus origin of DNA replication and its effect on viral interference
ATE142702T1 (de) Spezifischer nachweis von mycobacterium tuberculosis
Sauerbrei et al. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster
Hutchings et al. Methylation Status of theEpstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and LymphoblastoidCell Lines
EP0540135A3 (en) Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification
Nakayama et al. Tetrameric ring formation of Epstein-Barr virus polymerase processivity factor is crucial for viral replication
ES2048652A1 (es) Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
Korn et al. Adenovirus DNA synthesis in vitro is inhibited by the virus-coded major core protein
WO1999057284A3 (en) Attenuated influenza viruses
WO1997008531A3 (en) Detection of hepatitis gb virus genotypes
Ensser et al. Rhesus monkey rhadinovirus isolated from hemangioma tissue
Pedrali-Noy et al. Evidence of a repetitive sequence in vaccinia virus DNA
Dunham et al. Mutants of Bacillus subtilis bacteriophage φe defective in dTTP-dUTP nucleotidohydrolase
Umene Cleavage in and around the DR1 element of the A sequence of herpes simplex virus type 1 relevant to the excision of DNA fragments with length corresponding to one and two units of the A sequence